Randomized Phase II Trial of Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: CAO/ARO/AIO-12Emmanouil Fokas, Thomas Brunner, Anca‐Ligia Grosu et al.|Journal of Clinical Oncology|2019Cited by 536
Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Patients With Locally Advanced Rectal CancerEmmanouil Fokas, Katica Krajinovic, Anke Schlenska‐Lange et al.|JAMA Oncology|2021Cited by 349
The RENAISSANCE (AIO-FLOT5) trial: effect of chemotherapy alone vs. chemotherapy followed by surgical resection on survival and quality of life in patients with limited-metastatic adenocarcinoma of the stomach or esophagogastric junction – a phase III trial of the German AIO/CAO-V/CAOGISalah‐Eddin Al‐Batran, Stefan Paul Moenig, Thorsten Oliver Goetze et al.|BMC Cancer|2017Cited by 226
Perioperative chemo(radio)therapy versus primary surgery for resectable adenocarcinoma of the stomach, gastroesophageal junction, and lower esophagusUlrich Ronellenfitsch, Matthias Schwarzbach, Ralf‐Dieter Hofheinz et al.|Cochrane Database of Systematic Reviews|2013Cited by 178
Preoperative chemo(radio)therapy versus primary surgery for gastroesophageal adenocarcinoma: Systematic review with meta-analysis combining individual patient and aggregate dataUlrich Ronellenfitsch, Katrin Jensen, Matthias Schwarzbach et al.|European Journal of Cancer|2013Cited by 169